Radionuclide production at the TRIUMF facility
- UBC/TRIUMF PET Program, Vancouver (Canada)
The TRIUMF accelerators represent the most powerful and versatile radioisotope production facility in the world. The 500 MeV cyclotron has three beam-lines that can operate simultaneous covering beam energies from 70 to 550 MeV with beam current up to 150 {mu}A. In addition, Nordion International Incorporated operates two high powered cyclotrons for the commercial production of medical radionuclides. The CP42 and the TR30 cyclotrons accelerate H{sup {minus}} ions as does the 500 MeV cyclotron giving them the capability of simultaneous beam extraction as well. The CP42 extracts beams between 15 and 41 MeV with a beam current up to 180 {mu}A. The TR30 operates two beams of 30 MeV protons with beam current >250 {mu}A each. The new TR13 cyclotron (13 MeV protons) has been completed and is dedicated to research in support of the PET clinical research program on the UBC campus, the radiopharmaceutical chemistry program at TRIUMF and the continued support of radioisotope research projects on the UBC campus.
- OSTI ID:
- 199793
- Report Number(s):
- CONF-941129-; TRN: 95:005652-0293
- Resource Relation:
- Conference: 13. international conference on the application of accelerators in research and industry, Denton, TX (United States), 7-10 Nov 1994; Other Information: PBD: 1994; Related Information: Is Part Of Thirteenth international conference on the application of accelerators in research and industry; Duggan, J.L.; Morgan, I.L. [eds.]; PB: 201 p.
- Country of Publication:
- United States
- Language:
- English
Similar Records
Research and commercial isotope production at TRIUMF
New facilities and kaon factory designs for TRIUMF